Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson’s disease

被引:0
|
作者
E Lauretti
A Di Meco
S Merali
D Praticò
机构
[1] School of Medicine,Department of Pharmacology and Center for Translational Medicine
[2] Temple University,Department of Pharmaceutical Sciences
[3] School of Pharmacy,undefined
[4] Temple University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Environmental stressor exposure is associated with a variety of age-related diseases including neurodegeneration. Although the initial events of sporadic Parkinson’s disease (PD) are not known, consistent evidence supports the hypothesis that the disease results from the combined effect of genetic and environmental risk factors. Among them, behavioral stress has been shown to cause damage and neuronal loss in different areas of the brain, however, its effect on the dopaminergic system and PD pathogenesis remains to be characterized. The C57BL/6 mice underwent chronic restraint/isolation (RI) stress and were then treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), whereas the control mice were treated only with MPTP and the effect on the PD-like phenotype was evaluated. The mice that underwent RI before the administration of MPTP manifested an exaggerated motor deficit and impairment in the acquisition of motor skills, which were associated with a greater loss of neuronal tyrosine hydroxylase and astrocytes activation. By showing that RI influences the onset and progression of the PD-like phenotype, our study underlines the novel pathogenetic role that chronic behavioral stressor has in the disease process by triggering neuroinflammation and degeneration of the nigral dopaminergic system.
引用
收藏
页码:e733 / e733
相关论文
共 50 条
  • [21] Methylene Blue Ameliorates Olfactory Dysfunction and Motor Deficits in a Chronic MPTP/Probenecid Mouse Model of Parkinson's Disease
    Biju, K. C.
    Evans, Robert C.
    Shrestha, Kripa
    Carlisle, Daniel C. B.
    Gelfond, Jonathan
    Clark, Robert A.
    NEUROSCIENCE, 2018, 380 : 111 - 122
  • [22] Exercise induced behavioral recovery and plasticity in the MPTP-mouse model of Parkinson's disease
    Petzinger, G. M.
    Arevalo, P.
    Vuckovic, M.
    Turnquist, P.
    Hogg, E.
    Walsh, J.
    Akopian, G.
    Meshul, C.
    Abernathy, A.
    Ramirez, M.
    Fisher, B.
    Jakowec, M. W.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1546 - 1546
  • [23] Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease
    Crocker, SJ
    Smith, PD
    Jackson-Lewis, V
    Lamba, WR
    Hayley, SP
    Grimm, E
    Callaghan, SM
    Slack, RS
    Melloni, E
    Przedborski, S
    Robertson, GS
    Anisman, H
    Merali, Z
    Park, DS
    JOURNAL OF NEUROSCIENCE, 2003, 23 (10): : 4081 - 4091
  • [24] Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease
    Kurosaki, R
    Muramatsu, Y
    Kato, H
    Araki, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (01) : 143 - 153
  • [25] Mouse model of Parkinson's disease mimicking neuroinflammation
    Pierre, S.
    Figueiredo-Pereira, M. E.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2008, 26 (08) : 863 - 863
  • [26] Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model o Parkinson's disease
    Santoro, Matteo
    Fadda, Paola
    Klephan, Katie J.
    Hull, Claire
    Teismann, Peter
    Platt, Bettina
    Riedel, Gernot
    JOURNAL OF NEUROCHEMISTRY, 2023, 164 (02) : 121 - 142
  • [27] The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease
    Schwenkgrub, Joanna
    Zaremba, Malgorzata
    Joniec-Maciejak, Ilona
    Cudna, Agnieszka
    Mirowska-Guzel, Dagmara
    Kurkowska-Jastrzebska, Iwona
    PLOS ONE, 2017, 12 (07):
  • [28] Sex differences in the MPTP mouse model or Parkinson's disease
    Antzoulatos, E.
    Jakowec, M. W.
    Petzinger, G. M.
    Wood, R. I.
    MOVEMENT DISORDERS, 2008, 23 (01) : S25 - S25
  • [29] Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease
    Zheng, Meizhu
    Liu, Chunming
    Fan, Yajun
    Yan, Pan
    Shi, Dongfang
    Zhang, Yuchi
    NEUROPHARMACOLOGY, 2017, 116 : 412 - 420
  • [30] Transcranial Ultrasound Stimulation Suppresses Neuroinflammation in a Chronic Mouse Model of Parkinson's Disease
    Zhou, Hui
    Meng, Long
    Xia, Xiangxiang
    Lin, Zhengrong
    Zhou, Wei
    Pang, Na
    Bian, Tianyuan
    Yuan, Tifei
    Niu, Lili
    Zheng, Hairong
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2021, 68 (11) : 3375 - 3387